Productos adulterados
Soborno
Competencia
Ocultación de información
Medioambiental
Fraude
Comisiones ilegales
Publicidad engañosa
Etiquetado
Precios
Otros
Created with Raphaël 2.1.2
Allerganm
Allerganm
5
10
15
20
25
30
35
2
GlaxoSmith Kline
2
3
5
3
1
2
5
3
11
1
1
Johnson & Johnson
1
0
5
0
0
4
4
9
2
0
0
Pfizer
2
0
1
4
0
1
7
5
3
0
0
Merck
0
0
2
2
1
2
1
2
7
1
0
Novartis
1
0
1
0
1
5
0
4
5
0
0
Bayer
0
3
1
4
0
1
3
1
4
0
0
AstraZeneca
1
0
1
0
0
4
1
2
6
1
0
Bristol Myers Squibb
1
4
1
1
2
1
1
2
3
0
0
Schering-Ploughm
0
0
2
0
2
1
1
1
8
0
0
Abbott Laboratories
0
2
1
2
0
3
1
1
4
0
0
Amgen
0
0
0
1
0
3
1
3
5
0
0
Eli Lilly
0
0
1
0
0
1
1
7
1
0
0
Sanofi-Aventis
0
2
0
1
0
2
0
0
6
0
0
Wyethm
1
0
0
1
0
0
2
4
1
0
0
Boehringer Ingelheim
0
0
0
2
0
1
1
1
4
0
1
Forest Laboratoriesm
0
0
0
0
0
2
0
1
1
1
0
Mylan
0
1
0
0
0
0
1
0
4
0
1
Genzymem
0
0
0
0
0
0
1
2
1
0
0
Roche Group
0
0
0
0
0
0
1
1
0
0
0
Actavis (Watson)
0
0
0
0
0
0
0
0
2
0
0
Perrigo
0
1
0
0
0
0
0
0
0
0
0
Allerganm
0
0
0
0
0
0
0
1
0
0